Back to Search Start Over

COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity

Authors :
Heissig, Beate
Salama, Yousef
Iakoubov, Roman
Vehreschild, Joerg Janne
Rios, Ricardo
Nogueira, Tatiane
Vehreschild, Maria J. G. T.
Stecher, Melanie
Mori, Hirotake
Lanznaster, Julia
Adachi, Eisuke
Jakob, Carolin
Tabe, Yoko
Ruethrich, Maria
Borgmann, Stefan
Naito, Toshio
Wille, Kai
Valenti, Simon
Hower, Martin
Hattori, Nobutaka
Rieg, Siegbert
Nagaoka, Tetsutaro
Jensen, Bjoern-Erik
Yotsuyanagi, Hiroshi
Hertenstein, Bernd
Ogawa, Hideoki
Wyen, Christoph
Kominami, Eiki
Roemmele, Christoph
Takahashi, Satoshi
Rupp, Jan
Takahashi, Kazuhisa
Hanses, Frank
Hattori, Koichi
Heissig, Beate
Salama, Yousef
Iakoubov, Roman
Vehreschild, Joerg Janne
Rios, Ricardo
Nogueira, Tatiane
Vehreschild, Maria J. G. T.
Stecher, Melanie
Mori, Hirotake
Lanznaster, Julia
Adachi, Eisuke
Jakob, Carolin
Tabe, Yoko
Ruethrich, Maria
Borgmann, Stefan
Naito, Toshio
Wille, Kai
Valenti, Simon
Hower, Martin
Hattori, Nobutaka
Rieg, Siegbert
Nagaoka, Tetsutaro
Jensen, Bjoern-Erik
Yotsuyanagi, Hiroshi
Hertenstein, Bernd
Ogawa, Hideoki
Wyen, Christoph
Kominami, Eiki
Roemmele, Christoph
Takahashi, Satoshi
Rupp, Jan
Takahashi, Kazuhisa
Hanses, Frank
Hattori, Koichi
Publication Year :
2022

Abstract

Although there is strong evidence that SARS-CoV-2 infection is associated with adverse outcomes in certain ethnic groups, the association of disease severity and risk factors such as comorbidities and biomarkers with racial disparities remains undefined. This retrospective study between March 2020 and February 2021 explores COVID-19 risk factors as predictors for patients' disease progression through country comparison. Disease severity predictors in Germany and Japan were cardiovascular-associated comorbidities, dementia, and age. We adjusted age, sex, body mass index, and history of cardiovascular disease comorbidity in the country cohorts using a propensity score matching (PSM) technique to reduce the influence of differences in sample size and the surprisingly young, lean Japanese cohort. Analysis of the 170 PSM pairs confirmed that 65.29% of German and 85.29% of Japanese patients were in the uncomplicated phase. More German than Japanese patients were admitted in the complicated and critical phase. Ethnic differences were identified in patients without cardiovascular comorbidities. Japanese patients in the uncomplicated phase presented a suppressed inflammatory response and coagulopathy with hypocoagulation. In contrast, German patients exhibited a hyperactive inflammatory response and coagulopathy with hypercoagulation. These differences were less pronounced in patients in the complicated phase or with cardiovascular diseases. Coagulation/fibrinolysis-associated biomarkers rather than inflammatory-related biomarkers predicted disease severity in patients with cardiovascular comorbidities: platelet counts were associated with severe illness in German patients. In contrast, high D-dimer and fibrinogen levels predicted disease severity in Japanese patients. Our comparative study indicates that ethnicity influences COVID-19-associated biomarker expression linked to the inflammatory and coagulation (thrombo-inflammatory) response. Future studies will be necessary t

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1383744486
Document Type :
Electronic Resource